SignatureFD’s CRISPR Therapeutics CRSP Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$79.6K Sell
1,636
-39
-2% -$1.9K ﹤0.01% 1343
2025
Q1
$57K Sell
1,675
-82
-5% -$2.79K ﹤0.01% 1495
2024
Q4
$69.2K Sell
1,757
-160
-8% -$6.3K ﹤0.01% 1406
2024
Q3
$90.1K Sell
1,917
-28
-1% -$1.32K ﹤0.01% 1264
2024
Q2
$105K Sell
1,945
-15
-0.8% -$810 ﹤0.01% 1138
2024
Q1
$134K Buy
1,960
+58
+3% +$3.95K ﹤0.01% 1031
2023
Q4
$119K Sell
1,902
-222
-10% -$13.9K ﹤0.01% 1009
2023
Q3
$96.4K Buy
2,124
+236
+13% +$10.7K ﹤0.01% 1075
2023
Q2
$106K Sell
1,888
-17
-0.9% -$954 ﹤0.01% 1028
2023
Q1
$86.2K Buy
1,905
+244
+15% +$11K ﹤0.01% 1120
2022
Q4
$67.5K Sell
1,661
-364
-18% -$14.8K ﹤0.01% 1200
2022
Q3
$132K Buy
2,025
+253
+14% +$16.5K ﹤0.01% 827
2022
Q2
$108K Sell
1,772
-37
-2% -$2.26K ﹤0.01% 948
2022
Q1
$114K Buy
1,809
+1,069
+144% +$67.4K ﹤0.01% 971
2021
Q4
$56K Sell
740
-195
-21% -$14.8K ﹤0.01% 1276
2021
Q3
$105K Sell
935
-1,435
-61% -$161K ﹤0.01% 946
2021
Q2
$384K Sell
2,370
-90
-4% -$14.6K 0.02% 444
2021
Q1
$300K Buy
2,460
+1,545
+169% +$188K 0.01% 451
2020
Q4
$140K Buy
915
+115
+14% +$17.6K 0.01% 652
2020
Q3
$67K Sell
800
-65
-8% -$5.44K ﹤0.01% 854
2020
Q2
$64K Sell
865
-75
-8% -$5.55K ﹤0.01% 854
2020
Q1
$40K Buy
940
+275
+41% +$11.7K ﹤0.01% 967
2019
Q4
$41K Hold
665
﹤0.01% 1036
2019
Q3
$27K Hold
665
﹤0.01% 1123
2019
Q2
$31K Sell
665
-20
-3% -$932 ﹤0.01% 1054
2019
Q1
$24K Buy
685
+85
+14% +$2.98K ﹤0.01% 1120
2018
Q4
$17K Sell
600
-1,700
-74% -$48.2K ﹤0.01% 1188
2018
Q3
$102K Sell
2,300
-50
-2% -$2.22K 0.01% 630
2018
Q2
$138K Buy
2,350
+1,300
+124% +$76.3K 0.02% 502
2018
Q1
$48K Buy
+1,050
New +$48K 0.01% 747